Telemedicine-Related Opioid Use Disorder Services in Underserved Populations: A Qualitative Evaluation of the Waiver Era
Telemedicine and e-Health · 2025
DOI: 10.1089/tmj.2024.0278 ↗Kurz gefasst
Fachartikel in der Zeitschrift Telemedicine and e-Health, 2025. Verfasst von Omolola E Adepoju und 3 weiteren Autor:innen. Beteiligte Einrichtung: Humana Integrated Health Systems Sciences Institute, University of Houston, Houston, Texas, USA. Hauptthemen laut MEDLINE: Medically Underserved Area, Opioid-Related Disorders, Telemedicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMHD NIH HHS.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Humana Integrated Health Systems Sciences Institute, University of Houston, Houston, Texas, USA.
- Department of Health Systems and Population Health Sciences, Tilman J Fertitta Family College of Medicine, University of Houston, Houston, Texas, USA.
- University of Wyoming, Laramie, Wyoming, USA.
ORCID-Profile: Omolola E Adepoju
Förderung
- NIMHD NIH HHS
Zitieren
APA
Adepoju, O. E., Gilbert, L. R., Pham, C., & Singh, M. (2025). Telemedicine-Related Opioid Use Disorder Services in Underserved Populations: A Qualitative Evaluation of the Waiver Era. Telemedicine and e-Health. https://doi.org/10.1089/tmj.2024.0278
Vancouver
Adepoju OE, Gilbert LR, Pham C, Singh M. Telemedicine-Related Opioid Use Disorder Services in Underserved Populations: A Qualitative Evaluation of the Waiver Era. Telemedicine and e-Health. 2025. doi:10.1089/tmj.2024.0278
BibTeX
@article{Adepoju2025,
author = {Adepoju, Omolola E and Gilbert, Lauren R and Pham, Cecilia and Singh, Maya},
title = {Telemedicine-Related Opioid Use Disorder Services in Underserved Populations: A Qualitative Evaluation of the Waiver Era},
journal = {Telemedicine and e-Health},
year = {2025},
doi = {10.1089/tmj.2024.0278}
}
EUVIMED